Gold had fallen out of favor for many investors since war broke out in Ukraine.
Spot prices for gold ran as high as $2,066 in March 2022 before plummeting over 20% down to $1,630 in October of the same year.
Many investors switched to other assets like cryptocurrencies in search of...
Bullish and Bloated? Why Stocks Are Flying and What Might Bring Them Back Down
It’s official — the S&P 500 and Dow have wiped out their 2025 losses in dramatic fashion. Just a few weeks ago, markets were bogged down by trade tensions and bearish expectations. Today? They're buoyed by...
In a recent court filing, the FTC dropped its challenge to Amgen’s takeover bid of Horizon Therapeutics (NASDAQ: HZNP). The FTC sought to block the acquisition in an effort to strengthen its antitrust enforcement policies. The agency felt that the merger would potentially lead to anti-competititive practices and price...
Bitcoin has been surging lately. The cryptocurrency has rallied nearly 70% from $26,000 in October to recent highs of $44,000.
The popular cryptocurrency still has a way to go to get back to its historic price level of nearly $69,000, set in November 2021.
It appears that Bitcoin and other cryptocurrencies...
Forget the high-flying tech darlings that often steal the spotlight. This week, we're shining a light on the heroes of the AI revolution – the companies that might seem dull but are actually powering the future.
We're talking data centers, construction firms, and even utility companies – those steady, reliable...
Strong Earnings Are No Longer Enough
The investment community just watched one of the market’s most compelling narratives hit a significant speed bump. Nvidia, the undisputed kingmaker of the artificial intelligence boom, delivered an earnings report that was, by all accounts, extraordinarily good.
Yet, the market’s reaction was anything but celebratory,...
Big Pharma companies have built empires out of human pain without managing to come close to addressing the number one cause of disability in the world: Depression, a disease that costs the economy a trillion dollars in lost production every year.
But while Big Pharma is turning over billions in...
When the Numbers Don’t Add Up
This week’s investing puzzle just got more complicated, and it’s not just inflation, jobs, or rates. It’s whether the data we’re using to make decisions is even reliable in the first place.
That’s right. U.S. economic data, long considered the gold standard, is now under...
Welcome to The Market Pulse, your weekly dose of market insights from Global Investment Daily.
Today, we're challenging a Wall Street adage that might make you want to pack your bags and head for the beach: "Sell in May and go away." But before you start planning your summer getaway,...
Throughout the entire month of September, Bitcoin had been traveling in a lazy sideways channel, bouncing between a floor of 25150 and a high of 28000. Throughout September, the 200 Simple Moving Average(SMA, shown in red below) held up as a strong level if resistance, keeping Bitcoin from rallying.
Then...
